In our studies, astaxanthin (AST) exposure resulted in no decrease in viability of normal light density marrow cells, or of normal CD34+ cells and no inhibitory effect on BFU-E colony formation or primary AML blasts. The gene discussed is CD34; the disease is acute myeloid leukemia.